Healthcare

Vaginal Pessary Market Size to Surpass US$ 647.2 Mn by 2030

The global Vaginal Pessary market size is expected to be worth around US$ 647.2 Mn by 2030, according to a new report by Vision Research Reports.

Vaginal Pessary Market (By Type: Gellhorn, Ring, Donut, Others; By End-use: Hospitals, Ambulatory Surgical Centres, Clinics) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38315

Report Coverage Details
Market Size US$ 647.2 Mn by 2030
Growth Rate CAGR of 12.2% From 2021 to 2030
Base year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Type, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned CooperSurgical Inc., Bliss GVS Pharma, MedGyn, Panpac Medical Corporation, Bioteque America, Personal Medical Corporation, Dr. Arabin GmbH & Co. KG, Integra Lifesciences, Wallach Surgical Devices

Growth Factors

An increase in the demand for pessaries has been witnessed in recent years as compared to the surgeries performed for pelvic organ prolapse. Easy and convenient application has largely favored the growing usage of pessaries among patients.

According to the U.S. Census Bureau, the number of women aged 65 years and above in America would double by 2030 to reach over 40 million. Vaginal pessaries have a high success rate and minimal complication rate for the treatment of both incontinence and prolapse. When successfully fitted, they are associated with high patient satisfaction.

Key Players

  • CooperSurgical Inc.
  • Bliss GVS Pharma
  • MedGyn
  • Panpac Medical Corporation
  • Bioteque America
  • Personal Medical Corporation
  • Dr. Arabin GmbH & Co. KG
  • Integra Lifesciences
  • Wallach Surgical Devices

Market Segmentation

  • Type Outlook
    • Gellhorn
    • Ring
    • Donut
    • Others
  • End-use Outlook
    • Hospitals
    • Ambulatory Surgical Centres
    • Clinics
  • Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Sweden
      • Norway
      • Russia
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Australia
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Qatar
      • Turkey

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38315

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Vaginal Pessary Market, By Type

7.1.  Vaginal Pessary Market, by Type, 2021-2030

7.1.1.    Gellhorn

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Ring

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Donut

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Vaginal Pessary Market, By End-use

8.1.  Vaginal Pessary Market, by End-use, 2021-2030

8.1.1.    Hospitals

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Ambulatory Surgical Centres

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Clinics

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Vaginal Pessary Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Type (2016-2030)

9.1.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Type (2016-2030)

9.1.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Type (2016-2030)

9.1.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Type (2016-2030)

9.2.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Type (2016-2030)

9.2.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Type (2016-2030)

9.2.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Type (2016-2030)

9.2.5.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Type (2016-2030)

9.2.6.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Type (2016-2030)

9.3.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Type (2016-2030)

9.3.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Type (2016-2030)

9.3.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Type (2016-2030)

9.3.5.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Type (2016-2030)

9.3.6.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Type (2016-2030)

9.4.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Type (2016-2030)

9.4.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Type (2016-2030)

9.4.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Type (2016-2030)

9.4.5.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Type (2016-2030)

9.4.6.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Type (2016-2030)

9.5.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Type (2016-2030)

9.5.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Type (2016-2030)

9.5.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

Chapter 10.  Company Profiles

10.1.              CooperSurgical Inc.

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Bliss GVS Pharma

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              MedGyn

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Panpac Medical Corporation

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Bioteque America

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Personal Medical Corporation

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Dr. Arabin GmbH & Co. KG

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Integra Lifesciences

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Wallach Surgical Devices

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38315

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button